ArticleClinical & developmental immunology2011

Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation.

Sebastian Kobold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.